Spectra Plasmonics receives BioCreate funding from Ontario Genomics

Spectra Plasmonics CEO Malcolm Eade working with NFK Manager Graham Gibson on the SEM at NFK

Congratulations to Spectra Plasmonics on the announcement that Ontario Genomics, with FedDev Ontario, have funded a project through the BioCreate program. The program support SMEs in southern Ontario that are commercializing products or technologies in the health, food and agriculture, and cleantech sectors at TRL 4 or higher. Spectra Plasmonics has developed devices capable of ultra-sensitive detection of chemicals in biological matrixes utilizing surface-enhanced Raman scattering. The technology was originally reported by researchers in the Chemical Engineering Department at Queen’s based on devices fabricated at NFK, with the company graduating from the Queen’s Innovation Centre Summer Initiative (QICSI).

For more information, see the Ontario Genomics announcement.